Millipore Names New VP of Life Science Business Unit
John Sweeney to focus on technology development and partnerships
Sweeney joined Millipore in 2003 as Director of Strategy and Corporate Development. In that role, he was responsible for long range strategic planning and served as the lead on execution of key M&A and partnership transactions, including Millipore’s $1.4 billion acquisition of Serologicals.
In his most recent role, Sweeney transformed Millipore's web presence, generating double-digit growth. He also built the Bioscience Business Development team which has resulted in several innovation partnerships and the acquisitions of Guava and Epitome.
Sweeney is a graduate of the University of Pennsylvania and earned a Master of Business Administration degree from the Tuck School of Business at Dartmouth.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.